JPS55145616A - Hybrid cell line* antibody and method for manufacturing monoclonal antibody against human helper t cell - Google Patents

Hybrid cell line* antibody and method for manufacturing monoclonal antibody against human helper t cell

Info

Publication number
JPS55145616A
JPS55145616A JP5369080A JP5369080A JPS55145616A JP S55145616 A JPS55145616 A JP S55145616A JP 5369080 A JP5369080 A JP 5369080A JP 5369080 A JP5369080 A JP 5369080A JP S55145616 A JPS55145616 A JP S55145616A
Authority
JP
Japan
Prior art keywords
monoclonal antibody
cell line
against human
cell
human helper
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5369080A
Other languages
English (en)
Other versions
JPS6362519B2 (ja
Inventor
Chiyunnshiu Kun Patoritsuku
Goorudosutain Gideon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21871570&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS55145616(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of JPS55145616A publication Critical patent/JPS55145616A/ja
Priority to FR8107825A priority Critical patent/FR2480697B1/fr
Publication of JPS6362519B2 publication Critical patent/JPS6362519B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3061—Blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/966—Chemistry: molecular biology and microbiology involving an enzyme system with high turnover rate or complement magnified assay, e.g. multi-enzyme systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Hybrid Cells (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
JP5369080A 1979-04-26 1980-04-24 Hybrid cell line* antibody and method for manufacturing monoclonal antibody against human helper t cell Granted JPS55145616A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8107825A FR2480697B1 (fr) 1980-04-24 1981-04-17 Dispositif de support de la selle pour une bicyclette

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/033,639 US4381295A (en) 1979-04-26 1979-04-26 Monoclonal antibody to human helper T cells and methods of preparing same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP63101497A Division JPH0198477A (ja) 1979-04-26 1988-04-26 ＩｇＧモノクローナル抗体−生産性ハイブリドマ

Publications (2)

Publication Number Publication Date
JPS55145616A true JPS55145616A (en) 1980-11-13
JPS6362519B2 JPS6362519B2 (ja) 1988-12-02

Family

ID=21871570

Family Applications (2)

Application Number Title Priority Date Filing Date
JP5369080A Granted JPS55145616A (en) 1979-04-26 1980-04-24 Hybrid cell line* antibody and method for manufacturing monoclonal antibody against human helper t cell
JP63101497A Granted JPH0198477A (ja) 1979-04-26 1988-04-26 ＩｇＧモノクローナル抗体−生産性ハイブリドマ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP63101497A Granted JPH0198477A (ja) 1979-04-26 1988-04-26 ＩｇＧモノクローナル抗体−生産性ハイブリドマ

Country Status (22)

Country Link
US (1) US4381295A (ja)
EP (1) EP0018794B1 (ja)
JP (2) JPS55145616A (ja)
AT (1) ATE14454T1 (ja)
AU (1) AU544792B2 (ja)
CA (1) CA1170592A (ja)
DE (2) DE3070896D1 (ja)
DK (1) DK154087C (ja)
ES (1) ES8105151A1 (ja)
FI (1) FI75363C (ja)
GR (1) GR67298B (ja)
HK (1) HK23786A (ja)
IE (1) IE50459B1 (ja)
IL (1) IL59919A (ja)
MY (1) MY8600513A (ja)
NO (1) NO159883C (ja)
NZ (1) NZ193470A (ja)
PH (1) PH16656A (ja)
PT (1) PT71148B (ja)
SG (1) SG6586G (ja)
YU (1) YU44957B (ja)
ZA (1) ZA802524B (ja)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5859994A (ja) * 1981-07-01 1983-04-09 ザ　ボード　オブ　リージェンツ，ザ　ユニバーシティ　オブ　テキサス　システム 組換えモノクローナル抗体
JPS5959630A (ja) * 1982-06-21 1984-04-05 デイナ−フア−バ−・キヤンサ−・インステイテユ−ト 特定抗原に特異的なモノクロ−ン抗体
JPS59196822A (ja) * 1983-02-16 1984-11-08 ディナーファーバー・キャンサー・インスティテュート・インコーポレイテッド モノクロ−ナル抗体
WO1985002188A1 (en) * 1983-11-09 1985-05-23 Toshitada Takahashi Novel monoclonal antibody
JPS61161221A (ja) * 1984-12-26 1986-07-21 ザ　ボード　オブ　トラステイズ　オブ　ザ　リーランド　スタンフオード　ジユニア　ユニバーシテイ Ｌｅｕ３表現型Ｔ細胞媒介性自己免疫病の治療用組成物
JPS62500450A (ja) * 1985-02-19 1987-02-26 ダナ−フア−バ−　キヤンサ−　インステイテユ−ト，インコ−ポレイテツド モノクロ−ナル抗体及びこれによる免疫化方法
US6790796B2 (en) 2001-10-05 2004-09-14 Albany International Corp. Nonwovens forming or conveying fabrics with enhanced surface roughness and texture
JP2006083183A (ja) * 1992-04-07 2006-03-30 Immunomedics Inc 臓器および組織の治療のための薬剤

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4381292A (en) * 1980-11-14 1983-04-26 The Board Of Trustees Of The Leland Stanford Jr. University Anti-human T-lymphocyte monoclonal antibody
US4824432A (en) * 1981-03-24 1989-04-25 S.V.S. Laboratories, Inc. Method for treating AIDS and other immune deficiencies and immune disorders
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4511662A (en) * 1982-06-18 1985-04-16 Bio-Rad Laboratories, Inc. Simultaneous assay for T and B lymphocyte populations and subpopulations
US4582790A (en) * 1983-02-15 1986-04-15 Wisconsin Alumni Research Foundation Monoclonal antibody to angiotension-converting enzyme and methods of preparing and using same
US4677056A (en) * 1983-08-18 1987-06-30 Sloan-Kettering Institute For Cancer Research Monoclonal antibody subsetting human helper and killer T-cells and method
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
USRE35277E (en) * 1983-09-11 1996-06-18 Yeda Research And Development Co. Ltd. Cell membrane proteins, compositions containing them and procedure for their preparation
US4645738A (en) * 1983-09-30 1987-02-24 Memorial Sloan-Kettering Institute Cancer Center Method for differential diagnosis of T cell leukemias using monoclonal antibodies
US4469630A (en) * 1983-11-25 1984-09-04 J. T. Baker Chemical Co. Purification of monoclonal antibodies
EP0146050B1 (en) 1983-12-16 1990-07-04 Denis M. Callewaert Site selective plasminogen activator and method of making and using same
US4965204A (en) * 1984-02-06 1990-10-23 The Johns Hopkins University Human stem cells and monoclonal antibodies
US5130144B1 (en) * 1984-02-06 1995-08-15 Univ Johns Hopkins Human stem cells and monoclonal antibodies
US4604235A (en) * 1984-05-23 1986-08-05 J. T. Baker Chemical Company Purification of monoclonal antibodies
ATE64855T1 (de) * 1984-09-14 1991-07-15 Pasteur Institut Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
FR2570278B1 (fr) * 1984-09-14 1987-02-13 Pasteur Institut Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise
DE3541033A1 (de) * 1985-11-19 1987-05-21 Boehringer Mannheim Gmbh Verfahren zur quantifizierung von zellpopulationen bzw. subpopulationen sowie hierfuer geeignetes reagenz
GB8608068D0 (en) * 1986-04-02 1986-05-08 Cobbold S P Monoclonal antibodies
CA1296622C (en) * 1986-08-12 1992-03-03 Jeffrey E. Anderson Method and apparatus for automated assessment of the immunoregulatory status of the mononuclear leukocyte immune system
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
US5068178A (en) * 1988-12-06 1991-11-26 Genetic Systems Corporation Method of enhancing direct immunofluorescence staining of cells
US7037496B2 (en) * 1989-12-27 2006-05-02 Centocor, Inc. Chimeric immunoglobulin for CD4 receptors
JPH0424999U (ja) * 1990-06-26 1992-02-28
GB9021677D0 (en) * 1990-10-05 1990-11-21 Xaar Ltd Method of testing multi-channel array pulsed droplet deposition apparatus
US5871732A (en) * 1990-11-27 1999-02-16 Biogen, Inc. Anti-CD4 antibody homologs useful in prophylaxis and treatment of AIDS, ARC and HIV infection
US5747265A (en) * 1992-10-30 1998-05-05 T Cell Diagnostics, Inc. Method for measuring the amount of a cell-associated molecule
RU2139092C1 (ru) * 1993-06-03 1999-10-10 Терапьютик Антибодиз Инк. Фрагменты антител в терапии
US5961976A (en) * 1996-06-03 1999-10-05 United Biomedical, Inc. Antibodies against a host cell antigen complex for pre- and post-exposure protection from infection by HIV
EP2065396A1 (en) 1996-08-30 2009-06-03 Human Genome Sciences, Inc. Interleukin-19
WO1999026658A1 (en) 1997-11-24 1999-06-03 Wong Johnson T Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
MX2008011785A (es) * 2006-03-16 2008-09-25 Genentech Inc Metodos de tratamiento de lupus utilizando anticuerpos cd4.
US20080279848A1 (en) * 2006-03-16 2008-11-13 Genentech, Inc. Methods of treating lupus using CD4 antibodies
AR077718A1 (es) * 2008-07-15 2011-09-21 Genentech Inc Metodos para tratar enfermedades autoinmunes usando anticuerpos anti cd4. formulacion farmaceutica
EP3194442A4 (en) 2014-09-16 2018-05-23 UBI IP Holdings Treatment and functional cure of hiv infection by monoclonal antibodies to cd4 mediating competitive hiv entry inhibition
US11292839B2 (en) 2016-08-13 2022-04-05 Ubi Us Holdings, Llc Treatment and sustained virologic remission of HIV infection by antibodies to CD4 in HAART stabilized patients

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5859994A (ja) * 1981-07-01 1983-04-09 ザ　ボード　オブ　リージェンツ，ザ　ユニバーシティ　オブ　テキサス　システム 組換えモノクローナル抗体
JPH0367678B2 (ja) * 1981-07-01 1991-10-23 Yunibaashitei Obu Tekisasu Shisutemu Za
JPS5959630A (ja) * 1982-06-21 1984-04-05 デイナ−フア−バ−・キヤンサ−・インステイテユ−ト 特定抗原に特異的なモノクロ−ン抗体
JPH0231957B2 (ja) * 1982-06-21 1990-07-17 Danaafuaabaa Kyansaa Inst Inc
JPS59196822A (ja) * 1983-02-16 1984-11-08 ディナーファーバー・キャンサー・インスティテュート・インコーポレイテッド モノクロ−ナル抗体
JPH0440999B2 (ja) * 1983-02-16 1992-07-06 Danaafuaabaa Kyansaa Inst Inc
WO1985002188A1 (en) * 1983-11-09 1985-05-23 Toshitada Takahashi Novel monoclonal antibody
JPS61161221A (ja) * 1984-12-26 1986-07-21 ザ　ボード　オブ　トラステイズ　オブ　ザ　リーランド　スタンフオード　ジユニア　ユニバーシテイ Ｌｅｕ３表現型Ｔ細胞媒介性自己免疫病の治療用組成物
JPH0840933A (ja) * 1984-12-26 1996-02-13 Univ Leland Stanford Jr Ｌｅｕ３表現型Ｔ細胞媒介性自己免疫病の治療用組成物
JPS62500450A (ja) * 1985-02-19 1987-02-26 ダナ−フア−バ−　キヤンサ−　インステイテユ−ト，インコ−ポレイテツド モノクロ−ナル抗体及びこれによる免疫化方法
JP2006083183A (ja) * 1992-04-07 2006-03-30 Immunomedics Inc 臓器および組織の治療のための薬剤
US6790796B2 (en) 2001-10-05 2004-09-14 Albany International Corp. Nonwovens forming or conveying fabrics with enhanced surface roughness and texture

Also Published As

Publication number Publication date
US4381295A (en) 1983-04-26
ATE14454T1 (de) 1985-08-15
EP0018794B1 (en) 1985-07-24
DE3070896D1 (en) 1985-08-29
SG6586G (en) 1986-08-01
ZA802524B (en) 1981-12-30
DK180580A (da) 1980-10-27
DK154087B (da) 1988-10-10
ES490943A0 (es) 1981-05-16
NO159883C (no) 1989-02-15
EP0018794A2 (en) 1980-11-12
AU5775880A (en) 1980-10-30
MY8600513A (en) 1986-12-31
PT71148A (en) 1980-05-01
AU544792B2 (en) 1985-06-13
FI75363B (fi) 1988-02-29
NO801216L (no) 1980-10-27
PT71148B (en) 1981-08-11
FI75363C (fi) 1988-06-09
IE800839L (en) 1980-10-26
IE50459B1 (en) 1986-04-30
NO159883B (no) 1988-11-07
JPH0198477A (ja) 1989-04-17
GR67298B (ja) 1981-06-29
JPS6362519B2 (ja) 1988-12-02
PH16656A (en) 1983-12-09
JPH0159867B2 (ja) 1989-12-20
ES8105151A1 (es) 1981-05-16
IL59919A0 (en) 1980-06-30
DE18794T1 (de) 1984-07-19
IL59919A (en) 1983-12-30
FI801343A (fi) 1980-10-27
YU114880A (en) 1985-04-30
DK154087C (da) 1989-02-27
HK23786A (en) 1986-04-11
NZ193470A (en) 1984-07-06
CA1170592A (en) 1984-07-10
YU44957B (en) 1991-06-30
EP0018794A3 (en) 1981-01-07

Similar Documents

Publication Publication Date Title
JPS55145616A (en) Hybrid cell line* antibody and method for manufacturing monoclonal antibody against human helper t cell
JPS5695123A (en) Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human prothymocyte cell
JPS5695121A (en) Hybrid cell line* antibody and method of manufacturing complementtfixing monoclonal antibody to human suppressor t cell
JPS56103115A (en) Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human t cell antigen
JPS5695122A (en) Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human early thymocyte cell
JPS5695120A (en) Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human thymocyte cell